Biochemistry, Genetics and Molecular Biology
Population
100%
Cohort Study
98%
Blood Pressure
93%
Autofluorescence
83%
Genome-Wide Association Study
70%
Awareness
68%
Prevalence
58%
Thyroid Function
47%
Genetics
43%
Thyroid Hormone
41%
Single Nucleotide Polymorphism
38%
Hematopoiesis
35%
Randomized Controlled Trial
35%
Body Mass
34%
Metabolomics
34%
Genotyping
25%
Advanced Glycation End-Product
24%
Thyroid-Stimulating Hormone
24%
Hemoglobin Blood Level
23%
Phenotype
23%
Prospective Cohort Study
23%
C-Peptide
23%
Systolic Blood Pressure
23%
Overall Survival
22%
Smoking
22%
Gene Linkage
22%
Health Survey
21%
Metabolite
20%
Cross Sectional Study
19%
Drug Megadose
19%
Diastolic Blood Pressure
19%
Lipid
18%
Low-Density Lipoprotein
18%
Blood Cell Count
17%
Comorbidity
17%
Waist Circumference
17%
Cyanocobalamin
16%
Cardiovascular Mortality
16%
Sex Difference
15%
Free Liothyronine Index
15%
Blood Pressure Regulation
15%
Pulse Pressure
15%
Genetic Determinism
15%
Genome Wide Association Study
14%
Single-Nucleotide Polymorphism
14%
Gene Locus
14%
Mean Arterial Pressure
13%
Genetic Variation
13%
Insulin Resistance
13%
Low Density Lipoprotein Cholesterol Level
13%
Medicine and Dentistry
Diabetes
83%
Maturity Onset Diabetes of the Young
79%
Quality of Life
72%
Insulin Dependent Diabetes Mellitus
71%
Population
60%
Autofluorescence
59%
Randomized Controlled Trial
54%
Cardiovascular Disease
51%
Blood Pressure
49%
Hydrocortisone
47%
Metabolic Syndrome
43%
Adrenal Insufficiency
38%
Biological Marker
37%
Cohort Analysis
35%
Drug Therapy
34%
Cardiovascular Mortality
32%
Anemia
32%
Disease
31%
Symptom
31%
Prospective Cohort Study
25%
Hemoglobin A1c
24%
Nicotine Patch
23%
Hematopoiesis
23%
Skin Manifestation
23%
Phenotype
23%
Advanced Glycation End-Product
23%
Prevalence
22%
Drug Megadose
21%
Genome Wide Association Study
21%
Cyanocobalamin
17%
Awareness
16%
Hypoglycemia
16%
Low Drug Dose
14%
Meta-Analysis
13%
Methylmalonic Acid
13%
C-Peptide
13%
Adenoma
13%
Thyroid Hormone
13%
Vitamin B12 Deficiency
13%
Depression
13%
Cardiovascular Risk
13%
Glucocorticoid
13%
Hyperglycemia
12%
Logistic Regression Analysis
12%
Systematic Review
11%
Insulin Resistance
11%
Erythrocytosis
11%
Sulfhemoglobinemia
11%
Clinical Population
11%
Glycogen Storage Disease
11%
Keyphrases
Skin Autofluorescence
83%
Type 1 Diabetes Mellitus (T1DM)
62%
Type I Diabetes
62%
Metabolic Syndrome
62%
Cardiovascular Disease
47%
Hydrocortisone
40%
Health-related Quality of Life
40%
Secondary Adrenal Insufficiency
36%
Cardiovascular Mortality
35%
Anemia
33%
Type 2 Diabetes Mellitus (T2DM)
33%
Hydrocortisone Dose
30%
High Dose
27%
Body Mass Index
26%
Netherlands
26%
Dutch
25%
Randomized Controlled Trial
23%
Thyroid Function
23%
Lipids
20%
Advanced Glycation End Products
19%
Population-based
18%
Metabolic Syndrome Prevalence
18%
Genome-wide Association Study
17%
Aging
16%
Thyroid Hormones
16%
Without Diabetes
16%
Continuous Glucose Monitoring
15%
Blood Pressure
15%
Hemoglobin A1c (HbA1c)
14%
Between-person
14%
Glycogen Storage Disease
14%
Low-density Lipoprotein Cholesterol (LDL-C)
14%
Metabolic Syndrome Components
14%
Thyroid Disorders
13%
Hypoglycemia Unawareness
13%
Metabolomics
13%
Hemoglobin Level
13%
Cause-specific Mortality
13%
Peripheral Blood
13%
Depressive Symptoms
13%
Comorbidity
13%
Blood Pressure Measurement
13%
Smoke Effect
13%
Non-invasive Biomarkers
12%
Antihypertensive Medication
12%
Low muscle Mass
11%
Adducin
11%
Diabetes Mellitus Prevention
11%
Mefloquine
11%
Metabolically Healthy Obesity
11%
